Navigation Links
The construction of heart modelling leads path to new therapies
Date:1/10/2008

Heart disease is still a major killer, especially in the western world, but new therapies based on stem cells and other techniques could now be imminent. Progress is being held back however by the difficulty testing new therapies on human heart tissue, with animal models being only of limited value owing to differences in structure and activity. The only solution in the absence of real human models is to create computerised in-silico models that simulate the real heart and enable possible drugs and therapies to be tested without risk to people. Although this is still some way off becoming a reality, substantial progress has been made, and the next steps were plotted at a major workshop held recently by the European Science Foundation (ESF).

The workshop highlighted how recent progress in imaging technologies was helping heart modellers overcome the big dilemma they have faced up till now actually proving that the models really are an accurate representation of the real human heart. This has been the big catch 22 of heart modelling, that in order to create a realistic model, you need accurate and extensive data from real hearts for calibration. Validation of the models is very important, and was raised at the workshop, said Blanca Rodriguez, scientific coordinator of the ESF workshop, and senior cardiac researcher at Oxford University, Europes leading centre for cardiac modelling. One of the problems has been that it is much easier to get experimental data from animals than humans.

Such animal data can help calibrate some aspects of the models, but only data from human hearts can fine tune them to the point at which they can actually make useful predictions and test therapies. Fortunately such data is now becoming available as a result of dramatic progress in imaging techniques that can observe cardiac activity externally without need for invasive probes. We are now getting data at very high resolutions, and that allows us to model things in
'/>"/>

Contact: Blanca Rodriguez
Blanca.Rodriguez@comlab.ox.ac.uk
44-018-652-73838
European Science Foundation
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Texel paleothermometer for climate reconstruction perfected
2. Vaginal reconstruction not needed for most inter-sex females, Hopkins study shows
3. Researchers take first steps towards spinal cord reconstruction following injury
4. Abnormal fat metabolism underlies heart problems in diabetic patients
5. High blood pressure, low energy -- a recipe for heart failure
6. Human derived stem cells can repair rat hearts damaged by heart attack
7. Geron Demonstrates hESC-derived cardiomyocytes improve heart function after myocardial infarction
8. Heart of Herschel to be presented to media
9. Minimally invasive heart surgery research wins NIH award
10. A step toward tissue-engineered heart structures for children
11. Research explains link between cholesterol and heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2015)... 2015 Research and ... of the  "Genetic Testing Market Outlook 2018" ... , ,A recent report, Genetic Testing Market ... the current and future genetic testing market. ... working principles and types are covered in ...
(Date:5/11/2015)... May 11, 2015  Synaptics Incorporated (NASDAQ: ... solutions, today announced the appointment of Wajid ... Financial Officer, reporting to Rick Bergman , ... Chief Financial Officer, Kathleen Bayless , who ... Mr. Ali brings extensive financial management expertise ...
(Date:5/8/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leading ... the executive management team will present at the following investor ... Telecom Conference Date: May 18, 2015 Time: 10:40am ... Cowen and Company Technology, Media & ... The New York Palace Hotel, New York, NY ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Synaptics to Present at Upcoming Investor Conferences 2
... ( www.ucr.edu ) The lab of a ... was named on Tuesday, April 3 after Innovation Economy ... research focused on using mobile devices, such as cell ... The technology being developed by Nosang Myung, professor and ...
... 30 millionth species occurrence record last week, making it ... animals and fungi. The Atlas, a collaboration between ... and Southern Cross Universities and the Commonwealth Government, reached ... Birdlife Australia were incorporated. Some of these records come ...
... A new gene that causes early-onset of Alzheimer,s disease has ... the Insert unit 1079 "Genetics of cancer and neuropsychiatric diseases" ... of 5 of 14 patients suffering from the disease, mutations ... production of a peptide involved in Alzheimer,s disease. The results ...
Cached Biology News:Using cell phones to detect harmful airborne substances 217th century Dutch explorers help the Atlas reach a major milestone -- 30 million records 2A new gene thought to be the cause in early-onset forms of Alzheimer's disease 2
(Date:5/22/2015)... , May 22, 2015 According ... Product (1D & 2D Gel Electrophoresis, Agarose & Polyacrylamide ... Reagents, Informatics), by Application & by End User - ... Market is expected to reach around $1.98 Billion by ... period 2015 to 2020. Browse 226 ...
(Date:5/22/2015)... 2015 Baylor Research Institute (BRI) at ... Research Institute (TGen) in Phoenix, AZ ... early detection and treatments for patients with a broad range ... lead to new clinical trials and access to technology to ... from bench to bedside across Baylor Scott & ...
(Date:5/21/2015)... Specialty Pharmacy Times has completed ... to BPA Worldwide as a business publication member. ... data for Specialty Pharmacy Times based on business/distribution, ... a member of BPA Worldwide, Specialty Pharmacy Times ... with the most reliable, unequaled data,” said Chris ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 uBiome, ... announced a partnership with PicnicHealth, a healthcare company ... Participants diagnosed with Inflammatory Bowel Disease (IBD) will ... a complementary uBiome research kit. Both companies were ... , For more information on this ...
Breaking Biology Technology:Electrophoresis Market Worth $1.98 Billion by 2020 2Electrophoresis Market Worth $1.98 Billion by 2020 3Electrophoresis Market Worth $1.98 Billion by 2020 4Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4Specialty Pharmacy Times Joins BPA Worldwide 2uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3
... Health Care (IHC) have announced a plan to ... adoption of electronic health records among U.S. health-care providers. ... Information and Management Systems Society (HIMSS) meeting in Dallas ... knowledge that IHC has gathered over the years and ...
... or process, having the next big thing is not ... marketplace, a mid-sized firm occupying several hard-won niches, or ... your success, says Tom Miller, an intellectual property lawyer ... a recent presentation to eInnovate, a Milwaukee-based technology forum, ...
... Small Tree Communications , a niche hardware ... a $445,000 funding round from Chippewa Valley Angel Investors ... to grow our business faster by getting our products to ... "It'll allow us to get office space and equipment, and ...
Cached Biology Technology:GE and Intermountain want to streamline nationwide patient data 2Protect your intellectual property before it's too late 2Protect your intellectual property before it's too late 3Chippewa Valley angels invest in network hardware company 2Chippewa Valley angels invest in network hardware company 3
Mouse monoclonal [SPM302] to BCAR1, prediluted ( Abpromise for all tested applications). entrezGeneID: 9564 SwissProtID: P56945...
Phosphotyrosine IgG mouse monoclonal antibody: Alkaline Phosphatase conjugate...
Rabbit polyclonal to Myosin VIIa (rating: *****) ( Abpromise for all tested applications). entrezGeneID: 4647 SwissProtID: Q13402...
Mouse monoclonal [6E10] to LAP2 ( Abpromise for all tested applications). entrezGeneID: 7112 SwissProtID: P42166...
Biology Products: